Young Shin Han

Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double‐blind, randomized, placebo‐controlled trial

Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double‐blind, randomized, placebo‐controlled trial.
Pediatr Allergy Immunol 2010: 21: e386–e393.
© 2009 John Wiley & Sons A/S

Association between filaggrin mutations and atopic dermatitis in Korean pregnant women

1 Lin RL, Szepietowski JC, Schwartz RA. Tinea faciei, an often deceptive facial eruption. Int J Dermatol 2004; 43: 437–440. 2 Gorani A, Oriani A, Cambiaghi S. Seborrheic dermatitislike tinea faciei. Pediatr Dermatol 2005; 22: 243–244. 3 Goulding JM, Todkill D, Carr RA, Charles-Holmes R. Pustules, plaques and pot-bellied pigs: difficulties in diagnosing tinea faciei. Clin Exp Dermatol 2010; 35: e10–e11. 4 Shrum JP, Millikan LE, Bataineh O. Superficial fungal infections in the tropics. Dermatol Clin 1994; 12: 687–693. 5 Bardazzi F, Raone B, Neri I, Patrizi A. Tinea faciei in a newborn: a new case. Pediatr Dermatol 2000; 17: 494–495. 6 Meymandi S, Wiseman MC, Crawford RI. Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol 2003; 48: S7–S8. 7 Patel G, Mills C. Tinea faciei due to Microsporum canis abscess formation. Clin Exp Dermatol 2000; 25: 608–610. 8 Polat M, Artüz F, Karaaslan A, et al. Seborrhoeic dermatitis-like tinea faciei in an infant. Mycoses 2007; 50: 525–526.

Changes in the antigenicity and allergenicity of ovalbumin in chicken egg white by N-acetylglucosaminidase

Ovalbumin (OVA), an (hen) egg allergen, is one of the most abundant glycoprotein allergens associated with IgE-mediated hypersensitivity through the T-helper type 2 immune response. The effect of deglycosylation of the N-terminal glycan in OVA on allergenicity and antigenicity after N-acetylglucosaminidase treatment was studied. N-acetylglucosaminidase-treated OVA (N-OVA) evaluated using an enzyme-linked immunosorbent assay, respectively. N-OVA significantly (p<0.05) OVA-specific IgE and histamine levels. In addition, N-OVA decreased the antigenicity of OVA 1000-fold. These results suggest that the degree of allergenicity and antigenicity reduced with deglycosylation of N-terminal glycan in OVA.